designation

Korean Temple Food: A Globally Recognized Sustainable Culinary Culture

Korean Temple Food, Designated as a National Intangible Cultural Heritage, Expands Its Global Reach Through International Events and Cultural DiplomacySEOUL,…

7 days ago

2026 Kia Sportage Named 2025 TOP SAFETY PICK+ in 2025 IIHS Crash Test Ratings

2026 Kia SPORTAGE earns highest-tier 2025 TOP SAFETY PICK+ (TSP+) rating from the U.S. Insurance Institute for Highway Safety (IIHS)Result…

1 month ago

Ofirnoflast (HT-6184) Receives Orphan Drug Designation from U.S. FDA for Myelodysplastic Syndromes

LEHI, Utah, Oct. 23, 2025 /PRNewswire/ -- Halia Therapeutics, Inc., a clinical-stage biopharmaceutical company pioneering therapies that target the root causes…

1 month ago

Hexaware Achieves AWS Premier Tier Status in the Amazon Web Services Partner Network

MUMBAI, India and ISELIN, N.J.  , Sept. 2, 2025 /PRNewswire/ -- Hexaware Technologies, a global provider of IT solutions and services,…

3 months ago

Galapagos NV Announces U.S. FDA Regenerative Medicine Advanced Therapy (RMAT) Designation Granted to GLPG5101 for the Treatment of Relapsed/Refractory Mantle Cell Lymphoma

Mechelen, Belgium; August 6, 2025, 7:30 CET; regulated information – inside information – Galapagos NV (Euronext & NASDAQ: GLPG) today…

4 months ago

Shanton Receives Fast Track Designation from US FDA for Refractory Gout Program

SAP-001 is Shanton's lead investigational compound with First- and Best-in-Class potential in uncontrolled gout SINGAPORE and PRINCETON, N.J., July 25,…

4 months ago

Chteau Galoupet unveils an exceptional brand home and launches its latest cuve

PARIS, July 17, 2025 /PRNewswire/ -- In July 2025, Château Galoupet, a historic Cru Classé within the prestigious Côtes-de-Provence designation and…

5 months ago

2025 Kia K4 earns 2025 IIHS TOP SAFETY PICK+ award

The 2025 Kia K4 has been awarded the Insurance Institute for Highway Safety’s (IIHS) highest safety rating, the 2025 TOP…

5 months ago

ArkBio’s New Drug Application for ADHD Therapeutic Azstarys Accepted and Granted Priority Review by China NMPA

SHANGHAI, June 16, 2025 /PRNewswire/ -- Shanghai Ark Biopharmaceutical Co., Ltd. ("ArkBio") today announced that the National Medical Products Administration…

6 months ago

Press Release: Rilzabrutinib granted orphan drug designation in the US for sickle cell disease

Rilzabrutinib granted orphan drug designation in the US for sickle cell disease Fourth orphan drug designation for rilzabrutinib in rare…

6 months ago